AssetMark’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
AssetMark's ANGO Position: Q3 2026 in Review
AssetMark increased its AngioDynamics (ANGO) stake by 100% in Q3 2026, buying an estimated $238 and bringing the position to 32 shares worth $492. The position accounts for ﹤0.01% of the portfolio, ranked #3412.
AssetMark first reported a position in ANGO in Q1 2017 and has held it in 13 quarters since. The position peaked at $5K in Q3 2017. 122 funds tracked by Wall St. Rank hold ANGO as of Q3 2026.
- AssetMark held 32 shares of AngioDynamics worth $492 as of Q3 2026.
- AssetMark bought 16 AngioDynamics shares in Q3 2026, an estimated $238.
- AngioDynamics made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3412 holding.
- AssetMark first reported a position in AngioDynamics in Q1 2017 and has held it in 13 quarters since.
- AssetMark's AngioDynamics position peaked at $5K in Q3 2017.
- 122 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.